Petra Herzig
- Immunology top 2%
- Immunotherapy and Immune Responses 9
- Immune Cell Function and Interaction 6
- Immune cells in cancer 3
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers 16
- CAR-T cell therapy research 11
-
- Diabetes Management and Research 2
-
- Diabetes and associated disorders 4
-
- Enzyme function and inhibition 2
- Co-authors
- Alfred ZippeliusDidier LardinoisG. GianiDaniela S. ThommenJoachim RosenbauerChristian KleinAndreas RollerVaios Karanikas
- Cited by
- ImmunologyOncologyCancer Research
- Partner nations
- SwitzerlandGermanyNetherlands
In The Last Decade
Petra Herzig
27 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Immunology 1.0k
- Oncology 1.3k
- Cancer Research 126
- Pulmonary and Respiratory Medicine 240
- Endocrinology, Diabetes and Metabolism 98
Countries citing papers authored by Petra Herzig
This map shows the geographic impact of Petra Herzig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Herzig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Herzig more than expected).
Fields of papers citing papers by Petra Herzig
This network shows the impact of papers produced by Petra Herzig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Herzig. The network helps show where Petra Herzig may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Petra Herzig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 16 | |
| 3 | 2023 | 8 | |
| 4 | 2023 | 2 | |
| 5 | An ex vivo tumor fragment platform to dissect response to PD-1 blockade in cancerbreakdown → | 2021 | 195 |
| 6 | 2021 | 2 | |
| 7 | 2021 | 28 | |
| 8 | 2020 | 65 | |
| 9 | 2019 | 10 | |
| 10 | 2019 | 42 | |
| 11 | A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockadebreakdown → | 2018 | 733 |
| 12 | 2016 | 4 | |
| 13 | 2015 | 112 | |
| 14 | 2015 | 315 | |
| 15 | 2015 | 28 | |
| 16 | 2007 | 103 | |
| 17 | 2003 | 50 | |
| 18 | 1998 | 18 | |
| 19 | A contribution to the problem of the epidemiological and clinical significance of Tahyna virus in the north Moravian region. | 1972 | 1 |
| 20 | [Comparison of the sensitivity of complement fixation tests, virus neutralization tests and the indirect immunofluorescence methods in the serologic diagnosis of tick-borne encephalitis]. | 1969 | 1 |
About Petra Herzig
Petra Herzig is a scholar working on Immunology, Oncology, Physiology, Genetics and Microbiology, having authored 27 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (16 papers), CAR-T cell therapy research (11 papers), Immunotherapy and Immune Responses (9 papers), Immune Cell Function and Interaction (6 papers), Diabetes and associated disorders (4 papers), Immune cells in cancer (3 papers), Enzyme function and inhibition (2 papers) and Diabetes Management and Research (2 papers). The work is most often cited by research in Immunology (1.0k citations), Oncology (1.3k citations), Cancer Research (126 citations), Pulmonary and Respiratory Medicine (240 citations) and Endocrinology, Diabetes and Metabolism (98 citations). Petra Herzig has collaborated with scholars based in Switzerland, Germany and Netherlands. Frequent co-authors include Alfred Zippelius, Didier Lardinois, G. Giani, Daniela S. Thommen, Joachim Rosenbauer, Christian Klein, Andreas Roller, Vaios Karanikas, Spasenija Savic Prince and Ton N. Schumacher. Their work appears in journals such as Nature Medicine, Journal of Thoracic Oncology, Diabetologia, OncoImmunology and Cancer Immunology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.